Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

Arvind N. Dasari, Sara Lonardi, Rocio García‐Carbonero et al. · The Lancet · 2023

Cited by 353 works. doi:10.1016/s0140-6736(23)00772-9

Authors

References